An investigation by NBC News sheds light on the inconsistencies in how states monitor issues related to peptides. The investigation reveals a disjointed system of oversight policies across different states.
The Case of Sarah Moran
Sarah Moran encountered significant side effects after taking a popular peptide dose in February. She reported experiencing a rapid heartbeat upon standing and persistent dizziness lasting for several days.
Current Oversight Challenges
Many experts believe there is inadequate regulation in place. They assert that allowing compounding pharmacies to produce certain peptides will not provide the necessary oversight.
Lack of Uniform Policies
Various states have adopted a patchwork approach to monitoring these substances. This lack of uniform policies poses risks to individuals like Sarah who may face adverse effects without sufficient regulatory protection.
Impact of Fake Smiles on Happiness 
Democratic Doctors and Scientists Enter Congress with New Agendas 
A Mother’s Journey with Her Newborn Son 
Experimental Heart Drug Fails to Meet Expectations in Crucial Study 
Popular Drinks Linked to Heart Attacks in Young Adults 
Illinois Faces Potential Ban on Hemp-Derived THC Products